Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875mg b.i.d. with cefuroxime 500mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults

Journal of Chemotherapy

Volumn 14, Issue 5, 2002, Pages 508-517

  Namyslowski, G ^a   Misiolek, Maciej ^a   Czecior, E ^a   Malafiej, E ^a   Orecka, B ^a   Namyslowski, P ^a   Misiolek, H ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Amoxycillin clavulanic acid; Cefuroxime axetil; Chronic and acute exacerbation of chronic sinusitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC SINUSITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EDEMA; ERADICATION THERAPY; EYE DISEASE; FACE EDEMA; FEMALE; GENITAL SYSTEM DISEASE; HEADACHE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEURALGIA; OPEN STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SINUSITIS; THRUSH; URTICARIA;

EID: 0036810536     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.5.508     Document Type: Article

References (16)

1. Gantz NM, Sogg AJ. An update on sinusitis. Patient Care 1992; 26: 141-163.
2. Kennedy DW. Overview. Otolaryngol Head Neck Surg 1990; 103: 847-854.
3. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209-1225.
4. Bartlett JG. Sinusitis. In: Management of Respiratory Tract Infections, Baltimore: Williams & Wilkins. 1997: Chapter 5: 199-227.
5. International Rhinosinusitis Advisory Board. Infectious rhinosinusitis in adults: Classification, etiology and management. Ear Nose Throat J 1997; 76 (Supplement): 3-22.
6. Gwaltney JM Jr, Scheld WM, Sande MA, et al. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: A fifteen year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457-462.
7. Jiang RS, Hsu CY, Leu JF. Bacteria of ethmoid sinus in chronic sinusitis. Am J Rhinol 1997; 11: 133-137.
8. Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the sub-set of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996; 347: 1507-1510.
9. Felmingham D. Antimicrobial resistance: Do we need new therapeutic approaches. Chest 1995; 108: 70-78.
10. Todd PA, Benfield P. Amoxycillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1990, 2: 264-307.
11. Dellamonica P. Cefuroxime axetil. Int J Antimicrob Agents 1994; 4: 23-36.
12. National Committee for Laboratory Standards. Approved Standard M2-A6. Performance Standards for Antimicrobial Disk Susceptability Tests. NCCLS, Wayne, Pa. 1997.
13. National Committee for Laboratory Standards. Approved Standard M7-A4. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. NCCLS, Wayne, Pa. 1997.
14. Doyle PW, Woodham JD. Evaluation of the microbiology of chronic ethmoid sinusitis. J Clin Microbiol 1991; 29: 2396-2440.
15. Hartog B, Degener JE, van Benthem PPG, et al. Microbiology of chronic maxillary sinusitis in adults: Isolated aerobic and anaerobic bacteria and their susceptibility to twenty antibiotics. Acta Otolaryngol 1995; 115: 672-677.
16. Fairbanks DNF. Inflammatory diseases of the sinuses: Bacteriology and antibiotics. Otolaryngol Clin N Am 1993; 26: 549-559.